Stent Thrombosis Clinical Trial
Official title:
Glasgow Natural History Study Of Covered Coronary Interventions
Covered stents (CS) are a potentially lifesaving treatment for grade III coronary perforation but delivery can be challenging, and the long-term durability and safety including risk of acute stent thrombosis are unknown. The GNOCCI study aims to evaluate long term outcomes after coronary perforation including patients treated with covered stents.
Covered stents (CS) are a potentially lifesaving treatment for grade III coronary perforation but delivery can be challenging, and the long-term durability and safety including risk of acute stent thrombosis are unknown. Using an electronic data base, details of all coronary perforations are identified and anonymised patient and procedural details are recorded.Procedural major adverse cardiac events (pMACE) are defined as a composite of death, myocardial infarction, stroke, target vessel revascularization or cardiac surgery within 24 hours of the index procedure. Two independent cardiologists adjudicate outcomes and differences in opinion are resolved by consensus with a third cardiologist. The overall GNOCCI study aims are: 1. Evaluate procedural and long term outcomes after coronary perforation 2. Long term safety and clinical events in patients treated with covered stents. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01205776 -
EXCEL Clinical Trial
|
N/A | |
| Completed |
NCT01231035 -
REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary Syndromes (RECLOSE 2 - ACS)
|
N/A | |
| Completed |
NCT01182428 -
XIENCE V: SPIRIT WOMEN Sub-study
|
Phase 4 | |
| Completed |
NCT04580602 -
Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects
|
||
| Completed |
NCT01205789 -
EXCEL Clinical Trial (Universal Registry)
|
N/A | |
| Completed |
NCT00647504 -
Prospective Clinical Observational Registry Including Consecutive Patients With In-stent Restenosis or Stent Thrombosis
|
N/A | |
| Active, not recruiting |
NCT00905008 -
Long-Term Safety of Drug Eluting Stents in the "Real World" (FReIburger STent Registry)
|
N/A | |
| Completed |
NCT03118895 -
Leaders Free III: BioFreedom™ Clinical Trial
|
N/A | |
| Completed |
NCT01249027 -
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
|
||
| Recruiting |
NCT06075602 -
COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease
|
||
| Completed |
NCT03209843 -
Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO)
|
N/A | |
| Completed |
NCT01086228 -
XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan
|
N/A | |
| Recruiting |
NCT05244629 -
Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia
|
N/A | |
| Completed |
NCT00998127 -
Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients
|
N/A | |
| Completed |
NCT00180479 -
SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)
|
Phase 3 | |
| Recruiting |
NCT04988685 -
SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters
|
||
| Completed |
NCT03544294 -
veRy Thin Stents for Patients With Left mAIn or bifurcatioN in Real Life: the RAIN a Multicenter Study
|
||
| Completed |
NCT04734028 -
PTRG-DES Consortium
|
||
| Completed |
NCT01894152 -
XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study
|
||
| Completed |
NCT00496938 -
XIENCE V: SPIRIT WOMEN
|
Phase 4 |